1 min read
Arrowhead Posts $450.82 Million in Revenue as GAAP EPS Misses
GAAP earnings per share was -$5.11, $1.51 below estimates; revenue missed estimates by $13.32 million.

Arrowhead Pharmaceuticals had GAAP earnings per share of -$5.11, missing estimates by $1.51. Revenue totaled $450.82 million, $13.32 million below estimates.